Mayne Pharma Group Ltd — Form D
Mayne Pharma Group Ltd of MELBOURNE, VICTORIA, C3, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-12. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-10-12
- Form: D
- Accession: 0001560183-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.7M
- Amount sold: $2.7M
- Minimum investment: $10K
- Investors: 14
- Date of first sale: 2012-09-27
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-185452
Issuer
- Name: Mayne Pharma Group Ltd
- CIK: 0001560183
- Entity type: Corporation
- Jurisdiction: AUSTRALIA
- Address: Level 14, MELBOURNE, VICTORIA, C3, 3000
- Phone: 61 3 9614 7022
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Andrew Dunbar | Executive Officer | Melbourne, Victoria, C3 |
| Phillip Tindall | Executive Officer | Melbourne, Victoria, C3 |
| Scott Richards | Director | Charlotte, NC |
| Scott Richards | Executive Officer | Charlotte, NC |
| Christelle Simpson | Executive Officer | Melbourne, Victoria, C3 |
| Leigh Willis | Executive Officer | Melbourne, Victoria, C3 |
| Stefan Cross | Executive Officer | Melbourne, Victoria, C3 |
| Roger Corbett | Director | Melbourne, Victoria, C3 |
| Ian Scholes | Director | Melbourne, Victoria, C3 |
| Peter Truelove | Executive Officer | Melbourne, Victoria, C3 |
| Stefan Lukas | Executive Officer | Melbourne, Victoria, C3 |
| Richard Moldin | Executive Officer | Melbourne, Victoria, C3 |
| Ron Best | Director | Melbourne, Victoria, C3 |
| Brenton Walter | Executive Officer | Melbourne, Victoria, C3 |
| Mark Cansdale | Executive Officer | Melbourne, Victoria, C3 |
| Stuart Mudge | Executive Officer | Melbourne, Victoria, C3 |
| Bruce Mathieson | Director | Melbourne, Victoria, C3 |
| Phil Hodges | Director | Melbourne, Victoria, C3 |
| Phil Hodges | Executive Officer | Melbourne, Victoria, C3 |
| Vince Caretti | Executive Officer | Melbourne, Victoria, C3 |
Other filings by this issuer (1)
More